Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Novel transplant regimen improves survival in primary immunodeficiency

Publish date:: March 6, 2019

Key clinical point: Allogeneic hematopoietic stem cell transplantation following a novel conditioning regimen showed success in adults and children with primary immunodeficiency.

Major finding: The 1-year overall survival and graft failure–free/graft-versus-host disease–free survival was 98% and 82%, respectively.

Study details: A prospective clinical trial involving 29 children and adults with various types of primary immunodeficiency.

Disclosures: Dr. Dimitrova reported having no financial disclosures.

Citation:

Dimitrova D et al. TCT 2019, Abstract 54.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Hematology

Emotions, worse attention linked to pain-related health care use SCD,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Large cohort study: Bevacizumab safe, effective for severe HHT bleeds,

SPK-8011 AAV-mediated Hemophilia A therapy shows stability, durability,

Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders,